Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers and is characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER-2). This evidence concerns the gene PGR and triple-negative breast carcinoma.